— Know what they know.
Not Investment Advice

NVOS OTC

Novo Integrated Sciences, Inc.
1W: -84.6% 1M: +0.0% 3M: -82.9% YTD: -77.8% 1Y: -88.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 52 · $11838 mcap · 18M float · 0.039% daily turnover · Short 43% of daily vol

📊 Key Metrics

TTM
$13M
Revenue
+5.7% YoY
$-16M
Net Income
-22.3% YoY
$-5M
Free Cash Flow
-121.4% YoY
51.2%
Gross Margin
-30.4%
Op. Margin
162.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-81.4%
ROA-47.8%
ROIC-35.0%

Valuation

P/E-0.0
P/B0.0
EV/EBITDA-1.5

Leverage

Debt/Equity0.32
Current Ratio0.37
Interest Cov.-1.2x

Quality Scores

Piotroski F3/9
Altman Z-4.26
Beneish M-3.20

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms